Industry
Medical - Instruments & Supplies
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Loading...
Open
21.66
Mkt cap
3.7B
Volume
4.1M
High
21.70
P/E Ratio
-2.74
52-wk high
25.64
Low
20.88
Div yield
N/A
52-wk low
15.14
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 6:34 pm
Portfolio Pulse from Avi Kapoor
October 31, 2024 | 3:29 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 2:13 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 1:25 pm
Portfolio Pulse from Benzinga Insights
October 31, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Insights
October 31, 2024 | 12:09 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 11:48 am
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 11:20 am
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:46 pm
Portfolio Pulse from Benzinga Insights
October 30, 2024 | 8:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.